May 15, 2017 / 12:49 PM / 4 months ago

BRIEF-ARCA Biopharma Q1 loss per share $0.48

May 15 (Reuters) - Arca Biopharma Inc

* Arca biopharma announces first quarter 2017 financial results and provides business update

* Q1 loss per share $0.48

* Arca biopharma - current cash, cash equivalents and marketable securities will be sufficient to fund operations, at its projected cost structure, through end of 2017

* Arca biopharma inc - cash, cash equivalents and marketable securities totaled $19.2 million as of march 31, 2017, compared to $23.5 million as of december 31, 2016

* Arca biopharma-expects g&a expenses in 2017 to be higher than in 2016 as it increases administrative activities to support genetic-af clinical trial Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below